Today, the vast majority of websites selling prescription drugs online are doing so illegally – many of them selling substandard/spurious/falsely-labelled/falsified/counterfeit medical products and drugs. NABP has reviewed more than 10,800 Internet drug outlets selling prescription medications and found nearly 97% to be out of compliance with United States pharmacy laws and practice standards that protect the public health. Of these websites identified as Not Recommended, nearly half offer foreign or non-Food and Drug Administration-approved drugs, and many distribute dangerous counterfeits to unsuspecting consumers.

NABP will establish the .pharmacy domain as a secure and trustworthy destination where consumers around the globe can be sure the medications they buy online are safe. NABP will ensure that all registrants within the .pharmacy generic Top-Level Domain (gTLD) are vetted prior to registration to confirm that they meet all applicable regulatory standards, including pharmacy licensure, drug authenticity, and valid prescription requirements, in the jurisdictions where they are based as well as where they serve patients.

NABP, with the support of a global coalition of stakeholders, applied to the Internet Corporation for Assigned Names and Numbers (ICANN) in June 2012 to own and operate the new .pharmacy gTLD. The application passed ICANN’s initial evaluation in May 2013 and, in February 2014, ICANN deemed NABP eligible to enter contract negotiations.

.Pharmacy and the Global Pharmacy Community

The .pharmacy TLD program will include a global pharmacy  coalition of stakeholders to ensure the program operates in a manner consistent with international laws and standards.

  • A standard setting committee will be established in each jurisdiction where the .pharmacy domain names will be sold. For example, there will be a National Standard Setting Committee for France, Japan, Germany, and so on.
  • The .pharmacy program will coordinate with international regulatory bodies when reviewing .pharmacy applications to ensure compliance with applicable laws.
  • The highest quality program standards will be maintained through participation in global forums to gather input from international .pharmacy stakeholders.

.Pharmacy Supporter Advisory Committee Reports

The .Pharmacy Supporter Advisory Committee was convened by the NABP Executive Committee and operates under the principles outlined in the NABP pharmacy governance document (PDF). The group also provides expertise and strategic input to the .pharmacy Executive Board and ultimately to the NABP Executive Committee for recommendations on establishing core (common) standards of operation that are universal to legitimate pharmacy practice and that will be required of all domain name registrants in the .pharmacy generic Top-Level Domain, consistent with the mission and purpose of the .pharmacy gTLD and the interests of the global public health.

Click below to read the committee’s reports.